Cantab seals pounds 11m deal with Glaxo
Wednesday 19 March 1997
The drugs giant is paying pounds 5m for the world-wide marketing and development rights for Cantab's DISC HSV vaccine for genital herpes and investing pounds 6m for a 4 per cent stake in the company. The shares, which have risen nearly 200p since the beginning of March, dived 60p to pounds 10.12p yesterday, but are still well up on the 560p at which they stood in October.
The deal with Glaxo, the world's leading herpes group, had been widely anticipated and analysts attributed the fall in the price to profit-taking. Duncan Moore at Morgan Stanley said it was a case of "buy on the rumour, sell on the news".
However, Jurek Sikorski, who joined Cantab as chief executive last August, welcomed yesterday's deal, which follows licensing deals for other potential drugs with Pfizer and SmithKline Beecham. "The signing of this agreement marks a significant step forward for Cantab," he said, "because all three are in the top 10 in the pharmaceuticals industry world-wide. I don't know any other biotechnology company which has more than three corporate partners in the top 10."
The results of UK phase I trials of the vaccine in 24 healthy volunteers will be announced at a strategy briefing today. If it reaches the market, expected early next century, HSV will represent the first vaccine in the Glaxo portfolio.
- 1 Michelle Obama highlights harsh restrictions faced by Saudi women after meeting King Salman without wearing a headscarf
- 2 Saudi preacher who 'raped and tortured' his five -year-old daughter to death is released after paying 'blood money'
- 3 Kim Kardashian on Bruce Jenner's 'story': 'We support him no matter what, and I think when the time is right, he'll talk'
- 4 Amal Clooney gives excellent response to fashion question at European Court of Human Rights
- 5 A bottle of wine a day is not bad for you and abstaining is worse than drinking, scientist claims
Saudi preacher who 'raped and tortured' his five -year-old daughter to death is released after paying 'blood money'
Michelle Obama highlights harsh restrictions faced by Saudi women after meeting King Salman without wearing a headscarf
Amal Clooney gives excellent response to fashion question at European Court of Human Rights
Isis publicly behead man in Syrian town square for 'insulting Allah' as he screams for help
One spelling error costs Companies House up to £9 million after being sued for ruining business
9 reasons Greece's experiment with the radical left is doomed to failure
'We would evict Queen from Buckingham Palace and allocate her council house,' say Greens
Greece elections: Syriza and EU on collision course after election win for left-wing party
British Muslim school children suffering a backlash of abuse following Paris attacks
British grandmother Lindsay Sandiford faces execution by firing squad in Indonesia
Liberal Democrat minister defends comments suggesting immigration causes pub closures
iJobs Money & Business
£13000 per annum: Recruitment Genius: This Pension Specialist was established ...
£23000 - £26000 per annum + Benefits: Ashdown Group: Market Research Executive...
£25000 - £35000 per annum: Recruitment Genius: A Technical Report Writer is re...
Competitive salary & benefits!: MBDA UK Ltd: MBDA UK LTD Indirect Procurement...